SCHEMBL25865421

SCHEMBL25865421

CCn1c(=O)oc2ccc(Br)nc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 2/20 0.43
SIRT2 Q8IXJ6 3/20 0.37
SIRT1 Q96EB6 3/20 0.37
PDE10A Q9Y233 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CBX7 O95931 1/20 0.34
CDYL2 Q8N8U2 1/20 0.34
CDYL Q9Y232 1/20 0.34
CDY1; CDY1B Q9Y6F8 1/20 0.34
HPGD P15428 2/20 0.34
USP2 O75604 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
ADORA3 P0DMS8 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA2B P29275 1/20 0.33
ADORA1 P30542 1/20 0.33
PIK3CD O00329 1/20 0.33
KMO O15229 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16362082 0.78 MAOB (0.33) ALDH1A1KDM4ESIRT2SIRT1HPGD
SCHEMBL20472133 0.76 KDM4E (0.43) ALDH1A1KDM4ESMN1; SMN2CBX7CDYL2
SCHEMBL20472203 0.76 KDM4E (0.41) ALDH1A1KDM4ECBX7CDYL2CDYL
SCHEMBL17418888 0.71 PDE4B (0.43) ALDH1A1KDM4ESIRT2SIRT1PDE10A
SCHEMBL616373 0.69 SIGMAR1 (0.53) ALDH1A1PDE10ASMN1; SMN2CBX7CDYL2
SCHEMBL30336433 0.69 SIGMAR1 (0.53) ALDH1A1PDE10ASMN1; SMN2CBX7CDYL2
SCHEMBL9589486 0.69 MIF (0.37) ALDH1A1KDM4EHPGDUSP2TSHR
SCHEMBL8919147 0.68 ALDH1A1 (0.37) ALDH1A1KDM4EPDE10ASMN1; SMN2HPGD
SCHEMBL28642857 0.68 CYP1A2 (0.47) KDM4ESMN1; SMN2TSHRADORA3ADORA2A
SCHEMBL28659735 0.68 PDE4A (0.41) ADORA2AADORA2BADORA1PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219938-A1 COMPOUNDS AND THEIR METHODS OF USE PRAXIS PREC MEDICINES INC (US) 2023-07-13 US disclosed
US-20230219938-A1 COMPOUNDS AND THEIR METHODS OF USE PRAXIS PREC MEDICINES INC (US) 2023-07-13 US disclosed
CN-113387962-A Pyrazolo [3,4-d ] pyrimidine-3-one derivative, pharmaceutical composition and application thereof 上海迪诺医药科技有限公司 2021-09-14 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219938-A1 COMPOUNDS AND THEIR METHODS OF USE SCN1A, SCN3A, SCN1B ALDH1A1 916/4885KDM4E 2066/4885SIRT2 1511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.